Crossmark

Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer’s Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model

Crossref DOI link: https://doi.org/10.1007/s12012-019-09543-8

Published Online: 2019-07-13

Published Print: 2020-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ellermann, Christian http://orcid.org/0000-0002-9172-296X
Coenen, Alix

Niehues, Philipp

Leitz, Patrick

Kochhäuser, Simon

Dechering, Dirk G.

Fehr, Michael

Eckardt, Lars

Frommeyer, Gerrit
License Information

Text and Data Mining valid from 2019-07-13

Version of Record valid from 2019-07-13
More Information

Article History

First Online: 13 July 2019

Compliance with Ethical Standards

:

: All other authors declare that they have no conflicts of interest.

: All applicable international, national, and institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution at which the studies were conducted.

Document is current

Any future updates will be listed below